Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.
Sobol
R E
RE
San Diego Regional Cancer Center, CA 92121, USA.
Royston
I
I
Fakhrai
H
H
Shawler
D L
DL
Carson
C
C
Dorigo
O
O
Gjerset
R
R
Gold
D P
DP
Koziol
J
J
Mercola
D
D
D017690:Cell Transplantation; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D003110:Colonic Neoplasms / Q000628:therapy*; D005347:Fibroblasts; D018014:Gene Transfer Techniques / Q000009:adverse effects; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007258:Informed Consent; D007376:Interleukin-2 / Q000235:genetics* / Q000627:therapeutic use
D007376:Interleukin-2